Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $148.73 million. The enterprise value is $9.94 million.

Market Cap	148.73M
Enterprise Value	9.94M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, after market close.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Adicet Bio has 82.17 million shares outstanding. The number of shares has increased by 4.78% in one year.

Shares Outstanding	82.17M
Shares Change (YoY)	+4.78%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	1.42%
Owned by Institutions (%)	68.00%
Float	49.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.87
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.41, with a Debt / Equity ratio of 0.12.

Current Ratio	8.41
Quick Ratio	n/a
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5,705.32

Financial Efficiency

Return on equity (ROE) is -65.60% and return on invested capital (ROIC) is -79.56%.

Return on Equity (ROE)	-65.60%
Return on Assets (ROA)	-55.80%
Return on Capital (ROIC)	-79.56%
Revenue Per Employee	n/a
Profits Per Employee	-$997,608
Employee Count	143
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.23% in the last 52 weeks. The beta is 1.62, so Adicet Bio's price volatility has been higher than the market average.

Beta (1Y)	1.62
52-Week Price Change	-70.23%
50-Day Moving Average	2.29
200-Day Moving Average	2.02
Relative Strength Index (RSI)	35.37
Average Volume (30 Days)	1,406,769

Short Selling Information

The latest short interest is 7.85 million, so 9.56% of the outstanding shares have been sold short.

Short Interest	7.85M
Short Previous Month	7.69M
Short % of Shares Out	9.56%
Short % of Float	16.00%
Short Ratio (days to cover)	5.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-152.04M
Pretax Income	-142.66M
Net Income	-142.66M
EBITDA	-133.69M
EBIT	-142.63M
Earnings Per Share (EPS)	-$3.31

Full Income Statement

Balance Sheet

The company has $159.71 million in cash and $20.92 million in debt, giving a net cash position of $138.79 million or $1.69 per share.

Cash & Cash Equivalents	159.71M
Total Debt	20.92M
Net Cash	138.79M
Net Cash Per Share	$1.69
Equity / Book Value	170.18M
Book Value Per Share	2.07
Working Capital	142.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$93.72 million and capital expenditures -$4.46 million, giving a free cash flow of -$98.18 million.

Operating Cash Flow	-93.72M
Capital Expenditures	-4.46M
Free Cash Flow	-98.18M
FCF Per Share	-$2.28

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.78%
Shareholder Yield	-4.78%
Earnings Yield	-95.92%
FCF Yield	-66.01%

Analyst Forecast

The average price target for Adicet Bio is $13.86, which is 665.75% higher than the current price. The consensus rating is "Buy".

Price Target	$13.86
Price Target Difference	665.75%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-26.42%

Stock Forecasts

Stock Splits

The last stock split was on September 16, 2020. It was a reverse split with a ratio of 1:7.

Last Split Date	Sep 16, 2020
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	2